Center for Drug Evaluation and Research, Approach to Addressing Drug Shortage; Public Workshop; Request for Comments
Document ID: FDA-2011-N-0690-0001
Comments
Total: 83
-
Janet Anderson Silvester - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0003 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Lloyd Wayne Nye - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0004 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Robert Paul Paone - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0005 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Michelle Rockey - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0006 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Richard Niel Maosn - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0007 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Robert Benjamin Zupancich - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0008 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Chris Ann Yeschke - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0009 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Mike Gillard - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0010 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Brian Baird - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0012 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
James Theodore Pollitz - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0013 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Gary Bruce Edwards - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0014 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
John Michael Canepa - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0015 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Darla Klementz - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0016 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Anonymous - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0017 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Carlin Ann Barbatti - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0018 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Kathryn K Davis - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0019 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
james thomas horton - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0021 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Lisa Bryan - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0022 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Christopher Dykstra - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0023 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Jennifer Lynn Morris - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0024 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Valerie Neal Barlow, PharmD, MBA - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0026 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Charles Rush Chaney Jr. - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0027 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Edward K Ocran - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0028 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Angela Black Smith - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0030 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Donna Wren - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0031 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Steven Lee Gratch - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0032 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Lehigh Valley Health Network - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0033 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Jennifer A Miller - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0034 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
Novation, LLC - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0035 Agency : FDA -
Dec 23,2011 11:59 PM ET
-
American Epilepsy Society - Comment
Posted : 12/21/2011 ID :FDA-2011-N-0690-0036 Agency : FDA -
Dec 23,2011 11:59 PM ET